Tait, J.R.; Bilal, H.; Rogers, K.E.; Lang, Y.; Kim, T.-H.; Zhou, J.; Wallis, S.C.; Bulitta, J.B.; Kirkpatrick, C.M.J.; Paterson, D.L.;
et al. Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics 2022, 11, 101.
https://doi.org/10.3390/antibiotics11010101
AMA Style
Tait JR, Bilal H, Rogers KE, Lang Y, Kim T-H, Zhou J, Wallis SC, Bulitta JB, Kirkpatrick CMJ, Paterson DL,
et al. Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics. 2022; 11(1):101.
https://doi.org/10.3390/antibiotics11010101
Chicago/Turabian Style
Tait, Jessica R., Hajira Bilal, Kate E. Rogers, Yinzhi Lang, Tae-Hwan Kim, Jieqiang Zhou, Steven C. Wallis, Jürgen B. Bulitta, Carl M. J. Kirkpatrick, David L. Paterson,
and et al. 2022. "Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model" Antibiotics 11, no. 1: 101.
https://doi.org/10.3390/antibiotics11010101
APA Style
Tait, J. R., Bilal, H., Rogers, K. E., Lang, Y., Kim, T.-H., Zhou, J., Wallis, S. C., Bulitta, J. B., Kirkpatrick, C. M. J., Paterson, D. L., Lipman, J., Bergen, P. J., Roberts, J. A., Nation, R. L., & Landersdorfer, C. B.
(2022). Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics, 11(1), 101.
https://doi.org/10.3390/antibiotics11010101
